Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wallmeier

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Der Radiologe|January 1, 1997
[Malignant lymphoma. Pathology, diagnosis, therapy]H Goldschmidt, M Wallmeier, U Hegenbart, et al.
Leukemia|January 22, 1998
High-dose chemotherapy in multiple myelomaH Goldschmidt, U Hegenbart, M Wallmeier, et al.
British Journal of Haematology|October 23, 1997
Factors influencing collection of peripheral blood progenitor cells following high-dose cyclophosphamide and granulocyte colony-stimulating factor in patients with multiple myelomaH Goldschmidt, U Hegenbart, M Wallmeier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1997
A quantitative PCR assay for the detection of low amounts of malignant cells in multiple myelomaF W Cremer, K Kiel, M Wallmeier, et al.
Experimental Hematology|September 5, 1998
Leukapheresis products in multiple myeloma: lower tumor load after mobilization with cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) compared with G-CSF aloneF W Cremer, K Kiel, M Wallmeier, et al.
American Journal of Hematology|April 17, 1998
Decreased numbers of circulating B cells in myeloma patients with reduction after conventional chemotherapyC Kallmeyer, M Wallmeier, K Kiel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1997
High-dose therapy with peripheral blood progenitor cell transplantation in multiple myelomaH Goldschmidt, U Hegenbart, M Wallmeier, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|September 26, 1997
Peripheral blood progenitor cell transplantation in multiple myeloma following high-dose melphalan-based therapyH Goldschmidt, U Hegenbart, M Wallmeier, et al.
Bone Marrow Transplantation|June 30, 1998
First and second apheresis in patients with multiple myeloma: no differences in tumor load and hematopoietic stem cell yieldK Kiel, F W Cremer, E Ehrbrecht, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|April 9, 1998
Increased risk of catheter colonization and catheter-related infections in severe immunocompromized patients with multiple myeloma undergoing high-dose glucocorticoid treatmentH Goldschmidt, H J Salwender, U Hahn, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Der Radiologe|January 1, 1997
[Malignant lymphoma. Pathology, diagnosis, therapy]H Goldschmidt, M Wallmeier, U Hegenbart, et al.
Leukemia|January 22, 1998
High-dose chemotherapy in multiple myelomaH Goldschmidt, U Hegenbart, M Wallmeier, et al.
British Journal of Haematology|October 23, 1997
Factors influencing collection of peripheral blood progenitor cells following high-dose cyclophosphamide and granulocyte colony-stimulating factor in patients with multiple myelomaH Goldschmidt, U Hegenbart, M Wallmeier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1997
A quantitative PCR assay for the detection of low amounts of malignant cells in multiple myelomaF W Cremer, K Kiel, M Wallmeier, et al.
Experimental Hematology|September 5, 1998
Leukapheresis products in multiple myeloma: lower tumor load after mobilization with cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) compared with G-CSF aloneF W Cremer, K Kiel, M Wallmeier, et al.
American Journal of Hematology|April 17, 1998
Decreased numbers of circulating B cells in myeloma patients with reduction after conventional chemotherapyC Kallmeyer, M Wallmeier, K Kiel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1997
High-dose therapy with peripheral blood progenitor cell transplantation in multiple myelomaH Goldschmidt, U Hegenbart, M Wallmeier, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|September 26, 1997
Peripheral blood progenitor cell transplantation in multiple myeloma following high-dose melphalan-based therapyH Goldschmidt, U Hegenbart, M Wallmeier, et al.
Bone Marrow Transplantation|June 30, 1998
First and second apheresis in patients with multiple myeloma: no differences in tumor load and hematopoietic stem cell yieldK Kiel, F W Cremer, E Ehrbrecht, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|April 9, 1998
Increased risk of catheter colonization and catheter-related infections in severe immunocompromized patients with multiple myeloma undergoing high-dose glucocorticoid treatmentH Goldschmidt, H J Salwender, U Hahn, et al.
Pageof 1